Zimmer Biomet Holdings (XSWX:ZBH) LT-Debt-to-Total-Asset: 0.28 (As of Mar. 2026)

What is Zimmer Biomet Holdings LT-Debt-to-Total-Asset?

Zimmer Biomet Holdings XSWX:ZBH -6.71% 65 LT-Debt-to-Total-Asset is 0.28 as of Mar. 2026. GuruFocus rates XSWX:ZBH with a GF Score™ of 65/100 and a GF Value™ of CHF101.85 (Significantly Undervalued). The stock has 3 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Zimmer Biomet Holdings's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.28.

Zimmer Biomet Holdings's long-term debt to total assets ratio declined from Mar. 2025 (0.30) to Mar. 2026 (0.28). It may suggest that Zimmer Biomet Holdings is progressively becoming less dependent on debt to grow their business.

Zimmer Biomet Holdings (XSWX:ZBH) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Zimmer Biomet Holdings LT-Debt-to-Total-Asset Related Terms

Zimmer Biomet Holdings LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Zimmer Biomet Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zimmer Biomet Holdings LT-Debt-to-Total-Asset Chart

Zimmer Biomet Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.23

0.25

0.23

0.25

0.30

Zimmer Biomet Holdings Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.30	0.30	0.32	0.30	0.28

65GF Score

Zimmer Biomet Holdings Inc XSWX:ZBH

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Zimmer Biomet Holdings LT-Debt-to-Total-Asset Calculation

Zimmer Biomet Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	5524.111	/	18401.776
	=	0.30

Zimmer Biomet Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	4956.132	/	17888.716
	=	0.28

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.28 mean?

Zimmer Biomet Holdings (XSWX:ZBH) has a LT-Debt-to-Total-Asset of 0.28 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Zimmer Biomet Holdings and its competitors.

Is Zimmer Biomet Holdings' LT-Debt-to-Total-Asset too high?

Zimmer Biomet Holdings' current LT-Debt-to-Total-Asset is 0.28. Overall, Zimmer Biomet Holdings has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Zimmer Biomet Holdings' LT-Debt-to-Total-Asset compare to STE and PEN?

Zimmer Biomet Holdings' LT-Debt-to-Total-Asset of 0.28 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?

A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Zimmer Biomet Holdings and its competitors. Zimmer Biomet Holdings's current LT-Debt-to-Total-Asset is 0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Zimmer Biomet Holdings stock overvalued right now?

Based on GuruFocus' analysis, Zimmer Biomet Holdings (XSWX:ZBH) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF101.85, compared to a current price of CHF69.50 — trading 31.8% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.28. Zimmer Biomet Holdings' overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current LT-Debt-to-Total-Asset is 0.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of CHF69.50 is trading 31.8% below its estimated GF Value™ of CHF101.85. GuruFocus considers Zimmer Biomet Holdings to be Significantly Undervalued.

Key valuation signals for XSWX:ZBH:

LT-Debt-to-Total-Asset: 0.28
GF Value™: CHF101.85 vs. price of CHF69.50 (31.8% below fair value)
GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zimmer Biomet Holdings Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies STE PEN GMED PODD BRKR DXCM GKOS BIO GEHC LIVN ABT SYK MDT BSX EW XTER:SHL XAMS:PHIA SZSE:300760 XSWX:SOON LSE:SN.

Other Exchanges ZBH:USA ZBH:Mexico 1ZBH:Italy ZIM:Germany Z1BH34:Brazil ZBH:Austria

Address 345 East Main Street, Warsaw, IN, USA, 46580

Website https://www.zimmerbiomet.com

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

65GF Score

Get the complete analysis for XSWX:ZBH

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF69.50

Price

CHF101.85

GF Value

View XSWX:ZBH Analysis

See LT-Debt-to-Total-Asset data for all stocks →